UNSPSC 51341802: Oseltamivir

This classification denotes an antiviral agent with the molecular formula C16H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 20O93L6F9H, chemically known as 1-cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3r,4r,5s)- but generally known as oseltamivir, which bears US NIH Compound Identifier 65028. European Medicines Agency schedules Oseltamivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03553MIG.

UNSPSC 51341802 Oseltamivir, a Commodity code, nominally covers an antiviral pharmaceutical, but recent state and local procurement activity under this code does not reflect purchases of oseltamivir itself. Instead, the posted opportunities tag naloxone, first aid and rescue supplies, generic pharmaceuticals, and over-the-counter products—a mismatch that suggests either data-entry error in the UNSPSC tagging or category drift in how jurisdictions use the code. State and local governments soliciting under 51341802 are procuring through a mix of issuing bodies: county health departments (Seminole County, Florida), city fire and rescue divisions (Tampa Fire Department), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (MMCAP, administered by Minnesota). The work being solicited ranges from emergency medical supplies and naloxone kits for opioid response to generic pharmaceutical stocking agreements and value-based pharmacy direct-to-manufacturer programs. Scope varies from discrete tactical buys (naloxone and drug deactivation systems) to strategic platform agreements spanning multiple drug classes and state jurisdictions.

Recent opportunities show activity concentrated in Florida, Texas, and the Upper Midwest. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly delivery requirements. The City of Tampa's Fire Department posted a sealed-bid solicitation (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies with an estimated contract value of $700,000 and a 5% small local business enterprise set-aside. The Texas HHS Commission released an RFI (HHS0017013, response due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. MMCAP, spanning Minnesota and Oregon, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with awards effective July 1, 2026. The code shows modest, geographically dispersed activity with no dominant repeat buyer and mixed notice types (IFB, RFI, RFP, sealed bid) reflecting both transactional buys and longer-term platform agreements.